Literature DB >> 19246142

CKD as an underrecognized threat to patient safety.

Jeffrey C Fink1, Jeanine Brown, Van Doren Hsu, Stephen L Seliger, Loreen Walker, Min Zhan.   

Abstract

Chronic kidney disease (CKD) is common, but underrecognized, in patients in the health care system, where improving patient safety is a high priority. Poor disease recognition and several other features of CKD make it a high-risk condition for adverse safety events. In this review, we discuss the unique attributes of CKD that make it a high-risk condition for patient safety mishaps. We point out that adverse safety events in this disease have the potential to contribute to disease progression; namely, accelerated loss of kidney function and increased incidence of end-stage renal disease. We also propose a framework in which to consider patient safety in CKD, highlighting the need for disease-specific safety indicators that reflect unsafe practices in the treatment of this disease. Finally, we discuss the hypothesis that increased recognition of CKD will reduce disease-specific safety events and in this way decrease the likelihood of adverse outcomes, including an accelerated rate of kidney function loss and increased incidence of end-stage renal disease.

Entities:  

Mesh:

Year:  2009        PMID: 19246142      PMCID: PMC3710448          DOI: 10.1053/j.ajkd.2008.12.016

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  53 in total

Review 1.  Metabolic and adverse effects of diuretics.

Authors:  C S Wilcox
Journal:  Semin Nephrol       Date:  1999-11       Impact factor: 5.299

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

3.  Severe hypermagnesemia as a result of laxative use in renal insufficiency.

Authors:  Fahim Zaman; Kenneth Abreo
Journal:  South Med J       Date:  2003-01       Impact factor: 0.954

Review 4.  Are drugs that block the renin-angiotensin system effective and safe in patients with renal insufficiency?

Authors:  M R Weir
Journal:  Am J Hypertens       Date:  1999-12       Impact factor: 2.689

5.  Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns.

Authors:  Allen R Nissenson; Allan J Collins; Judith Hurley; Hans Petersen; Brian J G Pereira; Earl P Steinberg
Journal:  J Am Soc Nephrol       Date:  2001-08       Impact factor: 10.121

6.  Guided medication dosing for inpatients with renal insufficiency.

Authors:  G M Chertow; J Lee; G J Kuperman; E Burdick; J Horsky; D L Seger; R Lee; A Mekala; J Song; A L Komaroff; D W Bates
Journal:  JAMA       Date:  2001-12-12       Impact factor: 56.272

7.  Management of patients with chronic renal insufficiency in the Northeastern United States.

Authors:  Annamaria T Kausz; Samina S Khan; Rekha Abichandani; Waqar H Kazmi; Gregorio T Obrador; Robin Ruthazer; Brian J G Pereira
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

8.  Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

Authors:  J Coresh; G L Wei; G McQuillan; F L Brancati; A S Levey; C Jones; M J Klag
Journal:  Arch Intern Med       Date:  2001-05-14

9.  Chronic kidney disease adversely influences patient safety.

Authors:  Stephen L Seliger; Min Zhan; Van Doren Hsu; Lori D Walker; Jeffrey C Fink
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

10.  Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality.

Authors:  Michelle Kittleson; Shelley Hurwitz; Monica R Shah; Anju Nohria; Eldrin Lewis; Michael Givertz; James Fang; John Jarcho; Gilbert Mudge; Lynne W Stevenson
Journal:  J Am Coll Cardiol       Date:  2003-06-04       Impact factor: 24.094

View more
  23 in total

1.  Contrasting Cholesterol Management Guidelines for Adults with CKD.

Authors:  Lisandro D Colantonio; Usman Baber; Maciej Banach; Rikki M Tanner; David G Warnock; Orlando M Gutiérrez; Monika M Safford; Christoph Wanner; George Howard; Paul Muntner
Journal:  J Am Soc Nephrol       Date:  2014-11-13       Impact factor: 10.121

2.  Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial.

Authors:  Matthew R Weir; Lisa Gravens-Muller; Nadiesda Costa; Anastasia Ivanova; Wana Manitpisitkul; Andrew G Bostom; Clarissa J Diamantidis
Journal:  Transplantation       Date:  2015-05       Impact factor: 4.939

3.  Self-reported Medication Adherence and Adverse Patient Safety Events in CKD.

Authors:  Kailin L Hsu; Jeffrey C Fink; Jennifer S Ginsberg; Marni Yoffe; Min Zhan; Wanda Fink; Corinne M Woods; Clarissa J Diamantidis
Journal:  Am J Kidney Dis       Date:  2015-05-13       Impact factor: 8.860

4.  Consideration of ICD-9 code-derived disease-specific safety indicators in CKD.

Authors:  Iris R Hartley; Jennifer S Ginsberg; Clarissa J Diamantidis; Min Zhan; Loreen Walker; Gail B Rattinger; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 8.237

Review 5.  Chronic Kidney Disease Diagnosis and Management: A Review.

Authors:  Teresa K Chen; Daphne H Knicely; Morgan E Grams
Journal:  JAMA       Date:  2019-10-01       Impact factor: 56.272

6.  Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance.

Authors:  Lesley A Stevens; Gautham Viswanathan; Daniel E Weiner
Journal:  Adv Chronic Kidney Dis       Date:  2010-07       Impact factor: 3.620

7.  Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study.

Authors:  Gaëlle Breton; Marc Froissart; Nicolas Janus; Vincent Launay-Vacher; Claudine Berr; Christophe Tzourio; Catherine Helmer; Benedicte Stengel
Journal:  Nephrol Dial Transplant       Date:  2011-02-03       Impact factor: 5.992

8.  Patient-reported and actionable safety events in CKD.

Authors:  Jennifer S Ginsberg; Min Zhan; Clarissa J Diamantidis; Corinne Woods; Jingjing Chen; Jeffrey C Fink
Journal:  J Am Soc Nephrol       Date:  2014-02-20       Impact factor: 10.121

Review 9.  Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.

Authors:  G Zaza; S Granata; F Sallustio; G Grandaliano; F P Schena
Journal:  Clin Exp Immunol       Date:  2009-11-24       Impact factor: 4.330

10.  Enhancing collaborative pharmaceutical care for patients with chronic kidney disease: survey of community pharmacists.

Authors:  Lisa Zhu; Andrea Fox; Yu Chun Chan
Journal:  Can J Hosp Pharm       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.